Company Monitoring Page for Algeta

latest headlines for company on cafepharma

Top 10 Pharma M&A deals of 2013
Fierce Pharma
Thu, 04/17/14 - 08:29 am
Tags:
M&A, Amgen, ONYX Pharmaceuticals, Bausch & Lomb, Valeant Pharmaceuticals, Elan, Perrigo, Actavis, Warner Chilcott, Bristol-Myers Squibb, AstraZeneca, Pearl Therapeutics, Agila, Mylan, Salix, Santarus, Bayer, Algeta, Shire, ViroPharma
Bayer says takeover offer for Algeta successful
Reuters
Wed, 02/26/14 - 09:05 am
Tags:
Bayer, Algeta, M&A
Bayer Set to Acquire Algeta in First Quarter
Marketwatch
Mon, 02/24/14 - 10:07 am
Tags:
Bayer, Algeta, M&A
Pulse of J.P. Morgan 2014: Interviews with 17 biopharma execs
Fierce Biotech
Fri, 01/17/14 - 05:54 pm
Tags:
JPMHC 2014, Algeta, Macrogenics, Xencor, Acetylon, Enanta Pharmaceuticals, Clinigen, Iroko Pharmaceuticals, Protalix BioTherapeutics, Ambrx, Roche, Sialix, Verastem, pRED, Cubist Pharmaceuticals, Celgene, Otonomy, Lumena Pharmaceuticals
Bayer wins Norway cancer firm Algeta with raised $2.9 billion offer
Reuters
Thu, 12/19/13 - 11:30 am
Tags:
Algeta, Bayer, M&A
Bayer bids $2.4 billion for Norwegian cancer drug partner Algeta
Yahoo/Reuters
Tue, 11/26/13 - 08:48 am
Tags:
Bayer, M&A, Algeta
Norway's Algeta says prostate cancer drug makes solid U.S. debut
Reuters
Wed, 08/28/13 - 11:38 am
Tags:
Algeta, prostate cancer, Xofigo
Bayer, Algeta Win U.S. Approval for Prostate Cancer Drug
Bloomberg
Wed, 05/15/13 - 02:51 pm
Tags:
Bayer, Algeta, FDA, prostate cancer, Xofigo
Algeta Sees ’Widespread’ Interest in Thorium Cancer Technology
Bloomberg
Thu, 03/7/13 - 11:57 am
Tags:
Algeta, Thorium-227, cancer
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:39 am
Tags:
vortioxetine, Vectura, tofacitinib, Takeda, T-DM1, Sanofi, Roche, REGN727, Regeneron, Reata, QVA149, Pfizer, Odanacatib, Novartis, MorphoSys, Merck, macitentan, Lundbeck, Immunogen, GSK, GS-7977, Gilead, gantenerumab, Eliquis, darapladib, Bristol-Myers Squibb, Biogen Idec, BG-12, Bayer, Bardoxolone, Anacetrapib, Alpharadin, Algeta, Actelion, AbbVie
Bayer Drug Hailed As Prostate Cancer Game Changer
TheStreet.com
Mon, 09/26/11 - 11:39 am
Tags:
Bayer, prostate cancer, Algeta, Amgen, Xgeva, Exelixis, Alpharadin
First Phase III trial of an alpha-pharmaceutical
eurekalert.org
Sat, 09/24/11 - 01:26 pm
Tags:
Bone metastases, prostate cancer, Alpharadin, Algeta, Bayer
Algeta shares spike on promising prostate cancer drug data
Fierce Biotech
Mon, 06/6/11 - 12:34 pm
Tags:
Algeta, prostate cancer, Apharadin
Algeta Announces First US Patient Randomized In ALSYMPCA Phase III Study At Tulane Cancer Center, New Orleans
Medical News Today
Sat, 12/12/09 - 01:28 pm
Tags:
Algeta, prostate cancer
Bayer to Pay Up to $800 Million for Algeta’s New Drug
Bloomberg
Thu, 09/3/09 - 08:45 am
Tags:
Bayer, Algeta, Alpharadin, prostate cancer

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.